Cogstate Ltd (ASX: CGS) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Cogstate Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $164.11 million
P/E Ratio 22.85
Dividend Yield 0.00%
Shares Outstanding 172.59 million
Earnings per share 0.032
Dividend per share N/A
Year To Date Return -34.95%
Earnings Yield 4.38%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Cogstate Ltd (ASX: CGS)
    Latest News

    young boys open mouthed in front of shares graph
    Share Market News

    Returning capital: These ASX companies have been buying back their shares in 2023

    Do you own any of these capital-returning shares?

    Read more »

    A young woman with her mouth open and her hands out showing surprise and delight as uranium share prices skyrocket
    Share Gainers

    Why CogState, Jumbo, Magellan, and St Barbara shares are rising today

    These ASX shares are having a positive session on Thursday.

    Read more »

    Rocket powering up and symbolising a rising share price.
    Earnings Results

    2 ASX All Ords stocks rocketing over 7% on strong results

    Guess which All Ords stock posted a 147% jump in profits last half.

    Read more »

    A worried man holds his head and look at his computer.
    Share Fallers

    Why Clinuvel, Cogstate, Omni Bridgeway, and Westgold shares are sinking

    These ASX shares are ending the week in a disappointing fashion...

    Read more »

    A man holds his head in his hands, despairing at the bad result he's reading on his computer.
    Earnings Results

    3 ASX All Ord shares being hammered on earnings today

    Investors have responded very negatively to these companies' results...

    Read more »

    a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
    Share Fallers

    Why A2 Milk, Altium, Cogstate, and Ingenia shares are sinking today

    Investors have been hitting the sell button on these shares on Tuesday...

    Read more »

    ASX shares downgrade A young woman with tattoos puts both thumbs down and scrunches her face with the bad news.
    Share Fallers

    Why CogState, Downer, Temple & Webster, and Woodside shares are dropping

    These ASX shares are dropping on Thursday...

    Read more »

    Small girl giving a fist bump with a piggy bank in front of her.
    Opinions

    These 2 small-cap ASX shares have soared, but a fund manager still tips them as buys

    Here are two picks in the WAM Microcap portfolio.

    Read more »

    a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
    Healthcare Shares

    2 ASX healthcare shares to buy that you've not heard of: expert

    If you want to invest in a sector that people still need during economic downturns, here's a pair of small…

    Read more »

    A young woman with glasses holds a pencil to her lips as she is surrounded by the reflection of data as though she is being photographed through a glass screen project with digital data.
    Technology Shares

    Here's how ASX tech shares fared in September

    It was mostly a sea of red for ASX tech shares in September...

    Read more »

    A women cheers with clenched fists having read some good news on her laptop.
    Share Gainers

    These were the 5 best-performing ASX All Ords shares in September

    These All Ords shares bucked the market weakness to shoot the lights out in September.

    Read more »

    Man drawing an upward line on a bar graph symbolising a rising share price.
    Share Gainers

    Why Cogstate, Global Lithium, Premier, and Woodside shares are charging higher

    These ASX shares are storming higher today...

    Read more »

    Frequently Asked Questions

    No, Cogstate does not pay dividends at this stage.

    Cogstate Ltd listed on the ASX on 13 February 2004.

    CGS ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Cogstate Ltd

    Cogstate Ltd (ASX: CGS) is a neuroscience technology company specialising in brain health assessments. The principal activity of the company is the sale of technology and services to measure cognition.

    The company provides licensed digital tests for health professionals and medical researchers. Its services include scientific consultancy, project management, data management, statistical analysis, and reporting. Cogstate generates the bulk of its revenue from its clinical trials segment. 

    Cogstate's technology has been used in more than 2,000 scientific and clinical trial studies. These include fields such as Alzheimer's, depression, and bipolar disorder research as well as studies investigating cognitive impairment in athletes as a result of concussive injuries.

    CGS Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Nov 2024 $0.97 $-0.01 -1.03% 34,854 $0.98 $0.98 $0.97
    12 Nov 2024 $0.98 $0.01 1.04% 41,911 $0.97 $0.98 $0.97
    11 Nov 2024 $0.97 $0.00 0.00% 47,642 $0.97 $1.00 $0.97
    08 Nov 2024 $0.97 $-0.01 -1.03% 31,376 $0.97 $0.97 $0.97
    07 Nov 2024 $0.97 $0.00 0.00% 27,389 $0.97 $0.97 $0.97
    06 Nov 2024 $0.97 $-0.01 -1.03% 146,337 $0.98 $0.98 $0.97
    05 Nov 2024 $0.98 $0.00 0.00% 68,358 $0.98 $0.99 $0.97
    04 Nov 2024 $0.98 $0.00 0.00% 63,308 $0.98 $0.98 $0.97
    01 Nov 2024 $0.98 $-0.01 -1.02% 119,399 $0.97 $0.98 $0.97
    31 Oct 2024 $0.98 $-0.02 -2.00% 108,871 $0.97 $1.00 $0.97
    30 Oct 2024 $1.00 $0.00 0.00% 244,229 $1.00 $1.04 $0.97
    29 Oct 2024 $1.00 $0.05 5.26% 68,715 $0.96 $1.00 $0.96
    28 Oct 2024 $0.95 $-0.03 -3.08% 136,274 $0.97 $0.98 $0.94
    25 Oct 2024 $0.98 $0.02 2.08% 41,581 $0.93 $0.98 $0.93
    24 Oct 2024 $0.96 $-0.01 -1.04% 151,259 $0.97 $0.97 $0.92
    23 Oct 2024 $0.97 $0.02 2.12% 448,920 $0.95 $1.00 $0.94
    22 Oct 2024 $0.95 $0.02 2.17% 23,953 $0.92 $0.95 $0.92
    21 Oct 2024 $0.92 $0.01 1.10% 77,061 $0.92 $0.93 $0.88
    18 Oct 2024 $0.91 $0.01 1.11% 38,085 $0.90 $0.91 $0.89
    17 Oct 2024 $0.90 $-0.02 -2.19% 23,978 $0.90 $0.90 $0.88
    16 Oct 2024 $0.92 $0.02 2.23% 90,488 $0.90 $0.92 $0.86
    15 Oct 2024 $0.90 $-0.01 -1.11% 71,539 $0.90 $0.90 $0.89

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    06 Nov 2024 Bradley O'Connor Issued 920,251 $920,251
    Issue of securities. Performance Rights: 920,251
    10 Sep 2024 Bradley O'Connor Exercise 1,000,000 $340,000
    Exercise of options.
    10 Sep 2024 Bradley O'Connor Issued 1,000,000 $340,000
    Exercise of options.
    23 Aug 2024 Martyn Myer Buy 100,000 $108,051
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Martyn Kenneth Myer Non-Executive ChairmanNon-Executive Director Oct 1999
    Mr Myer is Chair of the Doherty Institute at the University of Melbourne and the board of the Australian Chamber Orchestra. He is also a member of the Risk and Compliance Committee.
    Mr Bradley O'Connor Chief Executive OfficerManaging Director Nov 2005
    Mr O'Connor has responsibility for overall strategic direction and day-to-day operations as well as development of expansion opportunities outside of the core clinical trials business. Prior to that, Mr O'Connor held senior positions at Spherion Group, Australian Wine Exchange and PricewaterhouseCoopers.
    Ms Ingrid Anne Player Non-Executive Director Aug 2019
    Ms Player has considerable international commercial and regulatory experience that spans different markets and industries, which she gained in private legal practice in Australia and in The Netherlands. She has held senior executive roles with Healthscope Ltd, a private healthcare provider in Australia, including the former positions of Group Executive Legal, Governance and Sustainability, and General Counsel and Company Secretary from 2005 until 2019. She is Chair of Risk and Compliance Committee.
    Mr Richard van den Broek Non-Executive Director Aug 2010
    Mr van den Broek is founder and managing partner of HSMR Advisors LLC, a U.S. based fund manager with an investment emphasis on small and mid-cap biotech public companies. Prior to his time as an investor in the healthcare industry Mr van den Broek had a ten-year career as a biotech analyst, starting at Oppenheimer & Co., then Merrill Lynch, and finally at Hambrecht & Quist.
    Dr Richard Mohs Non-Executive Director Jan 2017
    Dr Mohs is currently Chief Scientific Officer for the Global Alzheimer's Platform (GAP) Foundation, a non- profit devoted to developing the speed and quality of Alzheimer's disease research. Richard also serves as a consultant to academic institutions, foundations, and biopharmaceutical companies, and is a member of the Board of Governors for the Alzheimer's Drug Discovery Foundation. He is also a member of the Risk and Compliance Committee.
    Ms Kim Wenn Non-Executive Director Nov 2020
    Ms Wenn brings technology experience and commercial expertise to the Board of Cogstate, with over 30 years of experience in innovation roles. Kim's experience includes, among other things, business strategy, governance and change management with a focus on digital disruption. He is also a member of the Risk and Compliance Committee.
    Mr David James Franks Company Secretary Feb 2021
    -
    Ms Kristi Geddes Joint Company Secretary Apr 2023
    -
    Darren Watson Chief Financial Officer
    -
    Pam Ventola Chief Science Officer
    -
    David James Franks Company Secretary
    -
    Rachel Colite Executive Vice President Clinical Trials
    -
    Kristi Geddes Joint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Dagmar Dolby Fund 25,732,802 15.10%
    Citicorp Nominees Pty Limited 25,414,142 14.90%
    National Nominees Limited 20,556,374 12.00%
    Myer & Myer Pty Ltd 14,424,569 8.40%
    HSBC Custody Nominees 12,717,797 7.40%
    Anacacia Pty Limited 10,976,129 6.40%
    J P Morgan Nominees Australia Pty Limited 9,550,619 5.60%
    Mpyer Investments Pty Ltd 6,061,872 3.50%
    Mr Bradley John O'Connor 3,488,429 2.00%
    BNP Paribas Nominees Pty Ltd 2,633,372 1.50%
    Myer & Myer Pty Ltd i 2,313,000 1.40%
    BNP Paribas Nominees Pty Ltd i 2,020,262 1.20%
    Mr Alistair David Strong 1,320,000 0.80%
    Beta Gamma Pty Ltd 1,220,000 0.80%
    Anacacia Pty Ltd 1,216,210 0.70%
    Mutual Trust Pty Ltd 1,129,806 0.70%
    Mr David Alexander Simpson and Mrs Dawn Gentry Simpson 1,000,689 0.70%
    BNP Paribas Noms Pty Ltd 985,588 0.60%
    Ronnocob Pty Ltd 917,173 0.50%
    HSBC Custody Nominees i 892,182 0.50%

    Profile

    since

    Note